Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT03484702 · COMPLETED
Trial details
- NCT number
- NCT03484702
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-05
- Primary completion
- 2023-12-15
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.